Pfizer stock comes with a rather formidable dividend yield of 3.92 percent, which, coupled with a strong growth rate, makes it one of the dividend superstars in the pharma sector. The stock currently trades almost midway between its 52 weeks low and high of $29.83 and $35.38 respectively and thus offers a good point to build a position. The company recently reported rather tepid quarterly numbers but made up for those with a few product approvals. Management’s decision to raise EPS guidance is also a sign of good things to come.
